Europe Grants DefenAge Skincare Master Patent for Its Core Technology

Posted By American Med Spa Association, Tuesday, September 3, 2019

Progenitor Biologics, LLC, the manufacturer and distributor of the revolutionary, evidence-based, anti-aging skincare products, DefenAge Skincare, is proud to announce that the European Patent Office has granted DefenAge's master patent that covers DefenAge's core technology. The patent is entitled "Stem Cell Stimulating Compositions," patent number: EP 3157504.
The patent protects the exclusive rights of DefenAge to use the spectrum of immune peptides called defensins in topical cosmetic formulations in a specific range of concentrations effective to provide an anti-aging effect on a global scale, specifically to substantially reduce the appearance of wrinkles, pore size, brown and age spots, and redness; to address uneven skin tone and surface imperfections; to improve skin's brightness, radiance, evenness and clarity; to normalize skin's oiliness and hydration; and to correct skin firmness, sagging contours, lines and irregularities in texture.
Read more at PR Newswire >>